Starpharma Holdings Announces Update on VivaGel Co
Post# of 12
BY NewsBites
— 12:01 AM ET 12/05/2014
AUSTRALIAN COMPANY NEWS BITES
SOURCED FROM INFORMATION LODGED WITH THE AUSTRALIAN STOCK EXCHANGE
Starpharma Holdings (SPHRF) announced that the planned launch timing of the VivaGel condom in Japan would be delayed following a review of the specific category of medical device classification by the Japanese regulatory authorities. The regulatory status of the VivaGel condom in other regions where the product is approved for sale (Australia and NZ) or is undergoing regulatory review is not affected and does not rely upon the Japanese classification or approval process. Since receiving regulatory certification for the VivaGel condom in Japan earlier in 2014, Okamoto Industries has been actively undertaking launch preparations for the product with a view to launching the product shortly.
Source: Morningstar (MORN)